Adverse Drug Reaction News Bulletins
ADR News Bulletin 2016 December (Volume 18 Number 3)
Audiences
Healthcare professional
Industry member
Product type
Therapeutic Products
1 December 2016
This article has been migrated from an earlier version of the site and may display formatting inconsistencies.
Bulletin Highlights:
Revised indication on the use of risperidone for treatment of dementia
HLA-B*1502 genotyping and carbamazepine-induced severe cutaneous adverse reactions
Restrictions on the use of codeine-containing products in children and adolescents
Flouroquinolones and potential risk of retinal detachment
List of Dear Healthcare Professional Letters on safety concerns
Idelalisib and the risk of serious infections
Click on the link below to download the issue in pdf: